Irene Papaspirou

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study

Christos Papadimitriou, Pavlos Papakostas, Maria Karina et al. · BMC Medicine · 2011 · 50 citations · Full text

Medicine, Oncology, Pharmacology +16

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab

George Fountzilas, Christos Christodoulou, Mattheos Bobos et al. · Journal of Translational Medicine · 2012 · 35 citations · Full text

Medicine, Molecular Biology, Oncology +17

Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer

Georgios Lazaridis, Sofia Lambaki, Georgia Karayannopoulou et al. · Strahlentherapie und Onkologie · 2014 · 30 citations

Medicine, Cancer Biology, Oncology +14

A Rare Case of Rectovaginal Endometriosis with Lymph Node Involvement

Nikolaos Thomakos, Alexandros Rodolakis, G. Vlachos et al. · Gynecologic and Obstetric Investigation · 2006 · 26 citations

Medicine, Gynecology, Pathology +11

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Pantelis Skarlos, C. Christodoulou, Konstantine T. Kalogeras et al. · Cancer Chemotherapy and Pharmacology · 2011 · 25 citations

Medicine, Oncology, Chemotherapy +15